Form 4: iRhythm Technologies' Chief Commercial Officer Sells Shares

Chad Patterson, Chief Commercial Officer of iRhythm Technologies, sold a portion of his holdings in the company's common stock on May 2, 2025, according to a Form 4 filing with the SEC.

Summary

• Chad Patterson, the Chief Commercial Officer of iRhythm Technologies, Inc. (IRTC), reported the sale of company stock on May 2, 2025.
• He sold 7,210 shares at a price of $119.75 per share and 1,300 shares at a price of $125 per share.
• Following these transactions, Patterson directly owns 49,930 shares of iRhythm Technologies stock.
• The sales were executed under a pre-arranged 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the sale of shares by a company officer. The sentiment is neutral as it simply reports a transaction.

Industry Context

Insider sales are a common occurrence and are closely watched by investors for signals about a company's prospects. A 10b5-1 trading plan allows insiders to sell shares over a predetermined period, often to avoid accusations of trading on non-public information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates

Keywords

iRhythm Technologies, IRTC, Chad Patterson, stock sale, Form 4, SEC, 10b5-1 trading plan, Chief Commercial Officer, insider trading